-
Specialists Eye Gazyva as a New Option for Lupus Nephritis, but ACR Guidelines Favor Benlysta and Lupkynis for Upfront Use, According to Spherix Global Insights
30 Apr 2025 17:39 GMT
… specialists to reconsider their treatment approaches, particularly around the … is expected to receive FDA approval for LN later … ’ role earlier in the treatment paradigm, particularly among newly … that the drug may draw share primarily from Benlysta, though …
-
GSK 'well positioned' to shoulder fresh US pharma tariffs as drugs giant's sales hit $7.5bn
30 Apr 2025 09:15 GMT
… month but exempted pharmaceutical products from those … medicine Jemperli and myelofibrosis treatment Ojjaara.
Meanwhile, turnover from meningitis vaccines … the lupus drug Benlysta and asthma treatment Nucala.
Consequently … major clinical trial programmes set to …
-
GSK plc (NYSE:GSK) Q1 2025 Earnings Call Transcript
01 May 2025 12:51 GMT
… resilience of our diverse medicines and vaccines portfolio. As Emma … quarter, and within that, Benlysta, our treatment for lupus grew 39%, … safety results, and no drug-resistant mutations. This promising … ’d switch if their doctor recommended it. So I …
-
GSK "well positioned" to weather pharma tariffs
30 Apr 2025 19:06 GMT
… -acting HIV drugs, severe asthma therapy Nucala (mepolizumab), and lupus medicine Benlysta (belimumab … than 50% to £415 million.
Vaccine sales reflected continuing weakness in … , with two of the five FDA product approvals expected this year …
-
Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
30 Apr 2025 16:21 GMT
… is now favored over Benlysta in a growing number … systemic manifestations. While Benlysta remains the most prescribed … rheumatologists and dermatologists that treatment options remain limited, … the service evaluates current treatment approaches, unmet needs, …
-
FDA starts review of Roche's Gazyva in lupus nephritis
05 Mar 2025 17:59 GMT
… . The FDA has awarded breakthrough status to the drug in this … the New England Journal of Medicine.
The primary results were … ;s Benlysta (belimumab), which became the first FDA-approved, targeted treatment for … from the phase 3 ALLEGORY trial in a broader SLE …
-
Drug reimbursement panel approves iptacopan for PNH reimbursement, rejects danicopan over cost concerns
07 Mar 2025 08:06 GMT
The Pharmaceutical Reimbursement Review Committee (PREC) has … two chronic immune thrombocytopenia (ITP) treatments—Tavalisse (fostamatinib) and Doptelet (avatrombopag … use of risk-sharing contract drugs. Benlysta (belimumab) was proposed and approved …
-
Global Benlysta Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
04 Mar 2025 18:02 GMT
… • Increasing demand for precision medicine.
• Greater awareness of … in immunology, innovative drug delivery systems, stronger … plc received FDA approval for the Benlysta (belimumab) autoinjector … treatment option for this condition.
How Is the Benlysta …
-
How long does Benlysta take to work?
03 Mar 2025 18:58 GMT
… about Benlysta, talk with your doctor. They will monitor you during your treatment … questions about Benlysta, talk with your doctor or pharmacist.
Disclaimer: Medical News … your doctor or another healthcare professional before taking any medication. The drug …
-
GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines
17 Feb 2025 06:39 GMT
… amp; Drug Performance
Specialty Medicines
GSK… treatment for severe asthma, and Benlysta … medicines and vaccines currently in development, including 19 in Phase III trials … biotech collaborations, reinforcing its commitment to developing cutting-edge treatments …